CIK: 0001631134 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Aug 15, 2024
Total Value ($000): $1,787,597 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Karuna Therapeutics Inc | 1,381,149 | $437,147 | 24.5% | $32.21 | — | COM | 48576A100 |
| — | RayzeBio Inc | 2,419,528 | $150,422 | 8.4% | $22.20 | — | COM | 75525N107 |
| NTRA | Natera Inc | 1,550,280 | $97,110 | 5.4% | $9.81 | +409.3% | COM | 632307104 |
| ASND | Ascendis Pharma A/S | 754,032 | $94,970 | 5.3% | $92.54 | — | SPONSORED ADR | 04351P101 |
| MRK | Merck & Co Inc | 857,971 | $93,536 | 5.2% | $90.48 | +7.0% | COM | 58933Y105 |
| — | Aerovate Therapeutics Inc | 3,758,686 | $85,059 | 4.8% | $22.83 | — | COM | 008064107 |
| AZN | AstraZeneca PLC | 850,577 | $57,286 | 3.2% | $71.57 | — | SPONSORED ADR | 046353108 |
| VERA | Vera Therapeutics Inc | 3,467,156 | $53,325 | 3.0% | $15.35 | -17.3% | CL A | 92337R101 |
| IDYA | IDEAYA Biosciences Inc | 1,458,881 | $51,907 | 2.9% | $22.12 | +34.9% | COM | 45166A102 |
| — | ImmunoGen Inc | 1,546,902 | $45,866 | 2.6% | $11.75 | — | COM | 45253H101 |
| ISRG | Intuitive Surgical Inc | 126,959 | $42,831 | 2.4% | $260.77 | +14.3% | COM | 46120E602 |
| LLY | Eli Lilly & Co | 64,525 | $37,613 | 2.1% | $575.10 | 0.0% | COM | 532457108 |
| CYTK | Cytokinetics Inc | 414,207 | $34,582 | 1.9% | $36.92 | -1.9% | COM | 23282W605 |
| CLDX | Celldex Therapeutics Inc | 844,008 | $33,473 | 1.9% | $33.15 | -11.3% | COM | 15117B202 |
| — | CymaBay Therapeutics Inc | 1,411,769 | $33,346 | 1.9% | $23.62 | — | COM | 23257D103 |
| IMTX | Immatics NV | 2,969,039 | $31,264 | 1.7% | $9.86 | -6.6% | SHS | N44445109 |
| SNY | Sanofi | 598,978 | $29,787 | 1.7% | $53.64 | — | SPONSORED ADR | 80105N105 |
| — | Inhibrx Inc | 772,957 | $29,372 | 1.6% | $24.47 | — | COM | 45720L107 |
| KVUE | Kenvue Inc | 1,206,939 | $25,985 | 1.5% | $21.04 | -12.5% | COM | 49177J102 |
| KURA | Kura Oncology Inc | 1,667,321 | $23,976 | 1.3% | $9.83 | 0.0% | COM | 50127T109 |
| SNDX | Syndax Pharmaceuticals Inc | 1,075,786 | $23,248 | 1.3% | $20.61 | -25.4% | COM | 87164F105 |
| — | Marinus Pharmaceuticals Inc | 1,772,699 | $19,269 | 1.1% | $8.68 | — | COM | 56854Q200 |
| SYK | Stryker Corporation | 62,788 | $18,802 | 1.1% | $275.11 | -0.1% | COM | 863667101 |
| INCY | Incyte Corp | 296,569 | $18,622 | 1.0% | $56.56 | 0.0% | COM | 45337C102 |
| GERN | Geron Corp | 8,814,497 | $18,599 | 1.0% | $2.21 | -12.2% | COM | 374163103 |
| — | Inozyme Pharma Inc | 4,280,308 | $18,234 | 1.0% | $14.88 | — | COM | 45790W108 |
| ELAN | Elanco Animal Health Inc | 1,193,885 | $17,789 | 1.0% | $11.61 | -2.5% | COM | 28414H103 |
| ARGX | argenx SE | 44,721 | $17,013 | 1.0% | $439.60 | — | SPONSORED ADR | 04016X101 |
| — | Y-mAbs Therapeutics Inc | 2,194,278 | $14,965 | 0.8% | $26.75 | — | COM | 984241109 |
| PHVS | Pharvaris N V | 510,441 | $14,318 | 0.8% | $20.23 | 0.0% | COM | N69605108 |
| DYN | Dyne Therapeutics Inc | 1,013,505 | $13,480 | 0.8% | $10.89 | -10.3% | COM | 26818M108 |
| — | Agenus Inc | 15,656,234 | $12,962 | 0.7% | $1.29 | — | COM | 00847G705 |
| SVRA | Savara Inc | 2,382,835 | $11,199 | 0.6% | $3.77 | +1.8% | COM | 805111101 |
| MIRM | Mirum Pharmaceuticals Inc | 352,397 | $10,403 | 0.6% | $30.17 | +0.3% | COM | 604749101 |
| CABA | Cabaletta Bio Inc | 429,395 | $9,747 | 0.5% | $16.81 | 0.0% | COM | 12674W109 |
| IMVT | Immunovant Inc | 222,553 | $9,376 | 0.5% | $27.88 | +32.0% | COM | 45258J102 |
| BSX | Boston Scientific Corp | 131,000 | $7,573 | 0.4% | $53.38 | 0.0% | COM | 101137107 |
| GPCR | Structure Therapeutics Inc | 174,838 | $7,126 | 0.4% | $50.42 | — | SPONSORED ADS | 86366E106 |
| MLTX | MoonLake Immunotherapeutics | 113,757 | $6,870 | 0.4% | $55.20 | -6.6% | CLASS A ORD | 61559X104 |
| PODD | Insulet Corp | 19,000 | $4,123 | 0.2% | $171.53 | 0.0% | COM | 45784P101 |
| IRWD | Ironwood Pharmaceuticals Inc | 331,099 | $3,788 | 0.2% | $9.89 | 0.0% | COM CL A | 46333X108 |
| — | Bolt Biotherapeutics Inc | 2,754,437 | $3,085 | 0.2% | $32.91 | — | COM | 097702104 |
| — | Nextcure Inc | 2,671,856 | $3,046 | 0.2% | $10.01 | — | COM | 65343E108 |
| DXCM | Dexcom Inc | 20,000 | $2,482 | 0.1% | $109.05 | -6.3% | COM | 252131107 |
| — | Cooper Cos Inc | 4,000 | $1,514 | 0.1% | $378.44 | — | COM | 216648402 |
| MASI | Masimo Corp | 12,800 | $1,500 | 0.1% | $93.21 | 0.0% | COM | 574795100 |
| — | Nucana PLC | 4,684,120 | $1,386 | 0.1% | $9.47 | — | SPONSORED ADR | 67022C106 |
| — | Agenus Inc | 1,600,000 | $1,325 | 0.1% | $1.29 | — | Call | 00847G705 |
| — | Fusion Pharmaceuticals Inc | 125,299 | $1,204 | 0.1% | $6.50 | — | COM | 36118A100 |
| — | Marinus Pharmaceuticals Inc | 100,000 | $1,087 | 0.1% | $8.68 | — | Call | 56854Q200 |
| — | Immatics NV | 318,372 | $930 | 0.1% | $3.54 | — | *W EXP 07/01/2025 | N44445117 |
| — | Ikena Oncology Inc | 363,479 | $716 | 0.0% | $2.72 | — | COM | 45175G108 |
| — | Nucana PLC | 2,400,000 | $710 | 0.0% | $4.99 | — | COMMON SHARES | GB00BYWYV |
| PDSB | PDS Biotechnology Corp | 142,635 | $709 | 0.0% | $8.36 | -40.5% | COM | 70465T107 |
| PEN | Penumbra Inc | 2,000 | $503 | 0.0% | $221.05 | 0.0% | COM | 70975L107 |
| GRTX | Galera Therapeutics Inc | 3,083,712 | $448 | 0.0% | $12.19 | -98.7% | COM | 36338D108 |
| FULC | Fulcrum Therapeutics Inc | 28,600 | $193 | 0.0% | $4.44 | 0.0% | COM | 359616109 |
| PEPG | PepGen Inc | 23,038 | $157 | 0.0% | $5.48 | 0.0% | COM | 713317105 |
| ESTA | Establishment Labs Hldgs Inc | 3,052 | $79 | 0.0% | $29.28 | 0.0% | COM | G31249108 |
| — | Spruce Biosciences Inc | 22,767 | $67 | 0.0% | $2.15 | — | COM | 85209E109 |
| SLNO | Soleno Therapeutics Inc | 1,200 | $48 | 0.0% | $28.45 | 0.0% | COM | 834203309 |
| VIR | Vir Biotechnology Inc | 4,495 | $45 | 0.0% | $9.14 | 0.0% | COM | 92764N102 |